COVID-19. Coronavirus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Giving 250 cc of kefir (twice a day) along with following the hospital diet for 14 days. Intervention 2: Control group: No intervention with kefir and only followin
Sponsors
Artesh University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Positive PCR-test confirming COVID-19 infection Having a moderate or severe level of the disease ICU patients (provided that there is no restriction on the consumption of certain food substances) Age between 20-60 years Administering 2 doses of Sinopharm vaccine Absence of food allergies
Exclusion criteria
Exclusion criteria: Pregnancy or lactating Use of anti-coagulant drugs No infection with the Covid-19 virus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: At the baseline and end of the intervention. Method of measurement: Thermometer.;C-Reactive Protein. Timepoint: At the baseline and end of the intervention. Method of measurement: kit (Bionik, Iran) with the BT3500 (Biotecnica Instruments SpA -Italy) auto-analyzer.;Erythrocyte Sedimentation Rate (ESR). Timepoint: At the baseline and end of the intervention. Method of measurement: Westergren Method.;Dyspnea. Timepoint: At the baseline and end of the intervention. Method of measurement: Clinical examintation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastrointestinal symptoms. Timepoint: At the baseline and the end of the intervention. Method of measurement: Clinical examination.;WBC. Timepoint: At the baseline and the end of the intervention. Method of measurement: Sysmex K-1000 Hematology Analyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRamin Gooruee
Artesh University of Medical Sciences
Outcome results
None listed